×
Performant Healthcare EBITDA 2011-2024 | PHLT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Performant Healthcare ebitda from 2011 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Performant Healthcare EBITDA 2011-2024 | PHLT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Performant Healthcare ebitda from 2011 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$89.4B
Cencora (COR)
$46.8B
DiDi Global (DIDIY)
$22.8B
Natera (NTRA)
$20.9B
ICON (ICLR)
$16.3B
Avantor (AVTR)
$15B
Revvity (RVTY)
$14.4B
BioMerieux (BMXMF)
$13.8B
Viatris (VTRS)
$13.5B
Solventum (SOLV)
$12.7B
CochLear (CHEOY)
$12.3B
Medpace Holdings (MEDP)
$10.5B
Doximity (DOCS)
$10B
EUROFINS SCIENT (ERFSF)
$9.6B
HealthEquity (HQY)
$8.9B
Charles River Laboratories (CRL)
$8.4B
Sonic Healthcare (SKHHY)
$8.2B
Amplifon S.p.A (AMFPF)
$6.1B
Bausch + Lomb (BLCO)
$6.1B
Organon (OGN)
$4.1B
Sotera Health (SHC)
$3.7B
BrightSpring Health Services (BTSG)
$3.2B
Alignment Healthcare (ALHC)
$2.8B
Concentras Parent (CON)
$2.7B
Surgery Partners (SGRY)
$2.6B
Premier (PINC)
$2.2B
PACS (PACS)
$2.1B
Ardent Health Partners (ARDT)
$2B
GeneDx Holdings (WGS)
$1.9B
Progyny (PGNY)
$1.8B